News of Note

EDNA ‘ETI’ CUKIERMAN APPOINTED MARVIN & CONCETTA GREENBERG CHAIR IN PANCREATIC CANCER RESEARCH

Edna “Eti” Cukierman, a Co-Director of The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase, has been appointed to the newly created Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research.

“Dr. Cukierman’s newest honor will enable further scientific discovery and the ability to push the limits of clinical delivery through investment in her as a faculty member of the highest caliber,” said Jonathan Chernoff, Cancer Center Director.

In academia, an endowed chair represents the highest honor an institution can bestow upon a faculty member. It provides the opportunity for the chair holder to deepen the impact of their work while honoring in perpetuity the chair’s namesake. Cukierman’s research focuses on pancreatic cancer, one of the deadliest and most difficult cancers to treat.

The endowed chair is funded with generous support from the estate of Concetta “Chet” Greenberg, an ardent champion of both cancer research and women in STEM during her life.

CARDONI

SANJAY S. REDDY APPOINTED
MARVIN S. GREENBERG, MD, CHAIR IN PANCREATIC CANCER SURGERY

Sanjay S. Reddy, a Co-Director of The Marvin and Concetta Greenberg Pancreatic Cancer Institute, has been appointed to the Marvin S. Greenberg, MD, Chair in Pancreatic Cancer Surgery.

“Dr. Reddy expresses a rare passion for providing the highest-quality care, fueled by the latest advances in pancreatic cancer research and surgical techniques,” said Robert Uzzo, President and CEO of Fox Chase.

Appointment to an endowed chair rewards a physician’s or scientist’s professional contributions, recognizes the value of their research endeavors, and safeguards the funding needed to continue innovative, groundbreaking work.

The chair is funded with generous support from the estate of Concetta “Chet” Greenberg, who was an ardent champion of cancer research during her life.

COLIN LENTON

IGOR ASTSATUROV APPOINTED TO PAUL F. ENGSTROM PROFESSORSHIP IN ONCOLOGY

Igor Astsaturov, a Co-Director of The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase, has been appointed inaugural holder of the Paul F. Engstrom Professorship in Oncology.

Engstrom, one of the most beloved and respected physicians ever to serve on the Fox Chase faculty, is a pioneer in cancer prevention and control who created one of the first programs in the country dedicated to this field — at a time when the notion of prevention was novel.

“A rare type of physician and researcher, Dr. Astsaturov dedicates himself to providing compassionate care driven by laboratory discoveries that will more accurately define the molecular makeup of a patient’s cancer and help design better treatment options in the future,” said Robert Uzzo, President and CEO of Fox Chase.

Astsaturov specializes in treating gastrointestinal malignancies, including pancreatic, colorectal, esophageal, liver, gall bladder, bile duct, and stomach cancers, as well as neuroendocrine tumors.

ED CUNICELLI

2023: A STRONG YEAR FOR PHILANTHROPY

The Fox Chase Cancer Center Institutional Advancement team raised a record $23.9 million in fiscal year 2023. These funds will enable new programs, expanded clinical services, and more cancer research.    

Noteworthy major gifts received in 2023 include a $10.8 million Charitable Remainder Trust to benefit the Marvin and Concetta Greenberg Pancreatic Cancer Institute, a $2 million estate commitment to create the Beatrice Mintz Chair in Cancer Research, and a $1 million grant from the W. M. Keck Foundation to the lab of John Karanicolas, Co-Leader of the Cancer Signaling and Microenvironment Research Program.

The tenth annual In Vino Vita Benefit and Wine Auction raised more than $2 million to help build an Advanced Treatment Center at Fox Chase, and the 24th annual Paws for the Cause dog walk raised more than $115,000. Save the dates: the 25th annual Paws for the Cause will be held on Sunday, September 15, 2024, and the 50th Anniversary Gala will be held on Saturday, September 28.